[1] Rogers RS 3rd. Complex aphthosis [J]. Adv Exp Med Biol, 2003, 528: 311-316. [2] 晋素丽, 耿发云. 灵杆菌多糖治疗顽固性复发性阿弗他溃疡的临床观察 [J]. 现代口腔医学杂志, 2008, 22(2): 217. [3] 中华口腔医学会口腔黏膜病专业委员会. 复发性阿弗他溃疡的诊疗指南(试行)[J]. 中华口腔医学杂志, 2012, 47(7): 402-404. [4] Baccaglini L, Lalla RV, Bruce AJ, et al. Urban legends: recurrent aphthous stomatitis [J]. Oral Dis, 2011, 17(8): 755-770. [5] Slebioda Z, Szponar E, Kowalska A. Etiopathogenesis of recurrent aphthous stomatitis and the role of immunologic aspects: literature review [J]. Arch Immunol Ther Exp (Warsz), 2014, 62(3): 205-215. [6] Almoznino G, Zini A, Mizrahi Y, et al. Elevated serum IgE in recurrent aphthous stomatitis and associations with disease characteristics [J]. Oral Dis, 2014, 20(4): 386-394. [7] Brozovic S, Vucicevic-Boras V, Bukovic D. Serum IgA, IgG, IgM and salivary IgA in recurrent aphthous ulceration[J]. Coll Antropol, 2001, 25(2): 633-637. [8] Ozyurt K, Celik A, Sayarlioglu M, et al. Serum Th1, Th2 and Th17 cytokine profiles and alpha-enolase levels in recurrent aphthous stomatitis [J]. J Oral Pathol Med, 2014, 43(9): 691-695. [9] Lewkowicz N, Kur B, Kurnatowska A, et al. Expression of Th1/Th2/Th3/Th17-related genes in recurrent aphthous ulcers [J]. Arch Immunol Ther Exp (Warsz), 2011, 59(5): 399-406. [10] Harrington LE, Mangan PR, Weaver CT. Expanding the effector CD4 T-cell repertoire: the Th17 lineage [J]. Curr Opin Immunol, 2006, 18(3): 349-356. [11] 陈谦明. 口腔黏膜病学[M]. 第4版. 北京: 人民卫生出版社, 2012: 64-69. [12] Hsu HC, Yang P, Wang J, et al. Interleukin 17-producing T helper cells and interleukin 17 orchestrate autoreactive germinal center development in autoimmune BXD2 mice [J]. Nat Immunol, 2008, 9(2): 166-175. [13] Weaver CT, Harrington LE, Mangan PR, et al. Th17: an effector CD4 T cell lineage with regulatory T cell ties [J]. Immunity, 2006, 24(6): 677-688. [14] 谢三祥, 丰琳, 朱声荣, 等. 转录因子RORγτ和FOXP3在口腔扁平苔藓病损组织中的表达及意义[J]. 上海口腔医学, 2014, 23(4): 472-476. [15] Ghoreschi K, Laurence A, Yang XP, et al. T helper 17 cell heterogeneity and pathogenicity in autoimmune disease [J]. Trends Immunol, 2011, 32(9): 395-401. [16] Hemdan NY, Birkenmeier G, Wichmann G, et al. Interleukin-17-producing T helper cells in autoimmunity[J]. Autoimmun Rev, 2010, 9(11): 785-792. [17] Kohno M, Tsutsumi A, Matsui H, et al. Interleukin-17 gene expression in patients with rheumatoid arthritis[J]. Mod Rheumatol, 2008, 18(1):15-22. [18] Benedetti G, Miossec P. Interleukin 17 contributes to the chronicity of inflammatory diseases such as rheumatoid arthritis [J]. Eur J Immunol, 2014, 44(2): 339-347. [19] Jadidi-Niaragh F, Mirshafiey A. Th17 cell, the new player of neuroinflammatory process in multiple sclerosis[J]. Scand J Immunol, 2011, 74(1): 1-13. [20] Komiyama Y, Nakae S, Matsuki T, et al. IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis [J]. J Immunol, 2006, 177(1): 566-573. [21] Roeleveld DM, van Nieuwenhuijze AE, van den Berg WB, et al. The Th17 pathway as a therapeutic target in rheumatoid arthritis and other autoimmune and inflammatory disorders[J]. Bio Drugs, 2013, 27(5):439-452. [22] 王栋, 李言君, 付爱丽, 等. Treg与IL-17在复发性口腔溃疡中表达的相关性研究 [J]. 实用口腔医学杂志, 2012, 28(4): 466-469. [23] 林佳如, 樊均明. 白细胞介素17在IgA肾病中引起IgA1糖基化异常的作用研究 [J]. 重庆医学, 2016, 45(28): 3907-3909. [24] 刘瑜, 赵宏霞, 曹敏, 等. 哮喘患儿血清白细胞介素-4、白细胞介素-17和干扰素-γ水平的检测 [J]. 中国实验诊断学, 2013, 17(4): 735-737. [25] Pan HF, Ye DQ, Li XP. Type 17 T-helper cells might be a promising therapeutic target for systemic lupus erythematosus [J]. Nat Clin Pract Rheumatol, 2008, 4(7): 352-353. [26] Garrett-Sinha LA, John S, Geffen SL. IL-17 and the Thl7 lineage in systemic lupus erythematosus[J]. Curr Opin Rheumatol, 2008, 20(5): 519-525. [27] Maddur MS, Vani J, Hegde P, et al. Inhibition of differentiation, amplification, and function of human TH17 cells by intravenous immunoglobulin [J]. J Allergy Clin Immunol, 2011, 127(3): 823-830. |